Genertec Universal Medical Group Company Limited (5UM) — Cash Flow-to-Debt Ratio
Genertec Universal Medical Group Company Limited (5UM) has a Cash Flow-to-Debt Ratio of -0.03x as of June 2023, meaning its operating cash flow of €-1.67 Billion could theoretically repay 0% of its total liabilities (€64.56 Billion) in one year. See 5UM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genertec Universal Medical Group Company Limited Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Genertec Universal Medical Group Company Limited across 10 annual periods. Also explore net asset growth rate of Genertec Universal Medical Group Company to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Genertec Universal Medical Group Company Limited (2016–2025)
Year-by-year debt coverage analysis for Genertec Universal Medical Group Company Limited. For market capitalisation and broader financial context, see 5UM market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | €5.78 Billion | €59.28 Billion | ▲ +440.7% |
| 2024 | 0.02x | €1.14 Billion | €63.16 Billion | ▼ -78.4% |
| 2023 | 0.08x | €4.99 Billion | €59.98 Billion | ▲ +131.4% |
| 2022 | 0.04x | €2.06 Billion | €57.17 Billion | ▲ +234.3% |
| 2021 | -0.03x | €-1.40 Billion | €52.28 Billion | ▼ -28.3% |
| 2020 | -0.02x | €-971.72 Million | €46.55 Billion | ▲ +49.2% |
| 2019 | -0.04x | €-1.82 Billion | €44.41 Billion | ▲ +73.5% |
| 2018 | -0.15x | €-5.73 Billion | €37.00 Billion | ▲ +7.6% |
| 2017 | -0.17x | €-5.07 Billion | €30.26 Billion | ▼ -57.6% |
| 2016 | -0.11x | €-2.38 Billion | €22.39 Billion | — |